Federal Contractor Profile
Emergent Manufacturing Operations Baltimore LLC
Federal contracting record: $498M obligated across 14 awards from 1 agencies, FY 2016–2025.
Company Profile
Parent UEI (Unique Entity Identifier)
N9DCUHYEUN26
CAGE Code
6EBP9
Address
5901 E LOMBARD ST, BALTIMORE, MD, 212246824
First Federal Award
Dec 2, 2015
Most Recent Award
Jul 10, 2025
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- Department of Health and Human Services$498M
100.0% of total obligations
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Mar 30, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | DEVELOPMENT OF A PLASMA-DERIVED POLYCLONAL ANTIBODY-BASED COVID-19 THERAPEUTIC | $946K → |
| Mar 23, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | EMERGENT CIADM MANUFACTURING CAPACITY RESERVATION AND EXPANSION | $23M |
| Jan 13, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | TESTING AND SHELF-LIFE EXTENSION OF USG-OWNED ADJUVANT FOR PANDEMIC PREPAREDNESS. | $900K |
| Jul 23, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | TO EXPAND THE PUBLIC-PRIVATE PARTNERSHIP WITH EMERGENT TO RESERVE THE CAPACITIES AND CAPABILITIES AT CONTRACTOR?S BAYVIEW CIADM FACILITY. | $30M |
| Jun 2, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | TESTING AND SHELF-LIFE EXTENSION OF USG-OWNED ADJUVANT FOR PANDEMIC PREPAREDNESS. | $33K |
| May 24, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | EMERGENT CIADM MANUFACTURING CAPACITY RESERVATION AND EXPANSION | $628M |
| Apr 2, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | DEVELOPMENT OF A PLASMA-DERIVED POLYCLONAL ANTIBODY-BASED COVID-19 THERAPEUTIC | $15M → |
| Dec 19, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | TESTING AND SHELF-LIFE EXTENSION OF USG-OWNED ADJUVANT FOR PANDEMIC PREPAREDNESS. | $2.2M |
| Feb 10, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | DEVELOPMENT OF THE MAPP BIOPHARMACEUTICAL VIRAL HEMORRHAGIC FEVER (VHF) MCM PLATFORMIGF::OT::IGF | $7.5M |
| Sep 28, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | IGF::OT::IGF CIADM TASK ORDER FOR THE DEVELOPMENT AND MANUFACTURING OF A WHOLE VIRION INACTIVATED ZIKA VIRUS VACCINE | $1.7M → |
| Jun 24, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 236210 | IGF::OT::IGF CIADM TASK ORDER FOR THE DEVELOPMENT AND MANUFACTURING OF A WHOLE VIRION INACTIVATED ZIKA VIRUS VACCINE | $18M → |
Want to win work like Emergent Manufacturing Operations Baltimore LLC?
Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.